New data from open-label extension portion of TAZPOWER study demonstrated improved cardiac function BOSTON, Oct. 17, 2019 /PRNewswire/ — Stealth BioTherapeutics ( MITO ), a clinical-stage biotechnology company focused...
July 19, 2017 Recently, at the 2017 UMDF Mitochondrial Medicine Symposium, Stealth BioTherapeutics shared very encouraging results from its second clinical trial for primary mitochondrial myopathy, the MMPOWER-2 study....
MitoAction, the Foundation for Mitochondrial Medicine and UMDF have jointly authored an editorial that was sent to major newspaper outlets across the United States. It is our hope that...
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Stealth BioTherapeutics Corp(NASDAQ:MITO) today announced an agreement for an option to co-develop and commercialize elamipretide for mitochondrial diseases. Currently being evaluated in a Phase...
BOSTON, Oct. 17, 2019 /PRNewswire/ — Stealth BioTherapeutics (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction,...
The thoughts and prayers of the entire mitochondrial disease community are with Charlie Gard and his mother and father, Chris Gard and Connie Yates. They have decided to withdraw...
Woburn, Mass.–(BUSINESS WIRE)—Courtagen Life Sciences Inc. announced today that the company will be shifting the core focus of its business to medicinal cannabis genetics and testing. As the company...
IRVING, Texas, March 01, 2018 (GLOBE NEWSWIRE) — Reata Pharmaceuticals, Inc. (Nasdaq:RETA) (Reata or Company), a clinical-stage biopharmaceutical company, today announced top-line data from the dose-escalation cohorts of the...
Emma Beal, left, and Kerry Ellis (actress and singer best known for her work in musical theatre and subsequent crossover into music) showing her support for #KissGoodbyeToMito The historic...
BOSTON, Oct. 7, 2019 /PRNewswire/ — Stealth BioTherapeutics (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction,...